Real-World Analysis of Belantamab Mafodotin Care Patterns in Patients With Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT05986682 · COMPLETED
Trial details
- NCT number
- NCT05986682
- Sponsor
- Duke University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-18
- Primary completion
- 2023-11-07
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.